Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 196 to 210 of 235 results for radiotherapy

  1. Transperineal biopsy for diagnosing prostate cancer (DG54)

    Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer

    Diagnostics guidance
    Published
    1 June 2023
    View recommendations

    Sections for DG54

  2. ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment (MIB39)

    NICE has developed a medtech innovation briefing (MIB) on ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment

    Medtech innovation briefing
    Published
    30 September 2015

  3. GID-MT563 NPi-200 for pupillary light reflex in critical care patients

    Discontinued [GID-MT563]

    Medical technologies guidance
    Discontinued

  4. Selpercatinib for treating advanced thyroid cancer with RET alterations (TA742)

    Evidence-based recommendations on selpercatinib (Retsevmo) for advanced thyroid cancer with RET alterations in people 12 years and older.

    Technology appraisal guidance
    Published
    3 November 2021
    View recommendations

    Sections for TA742

  5. Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590)

    This guidance has been updated and replaced by NICE interventional procedures guidance 752.

    Interventional procedures guidance
    Published
    23 August 2017

  6. Nivolumab with radiation therapy for previously untreated glioblastoma multiforme [ID1562]

    Discontinued [GID-TA10443]

    Technology appraisal guidance
    Discontinued

  7. The MAGEC system for spinal lengthening in children with scoliosis (MT169)

    Discontinued [GID-MT544]

    Medical technologies guidance
    Discontinued

  8. Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (TA524)

    Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive Hodgkin lymphoma in adults.

    Technology appraisal guidance
    Published
    13 June 2018
    View recommendations

    Sections for TA524

  9. Electrochemotherapy for the treatment of malignant melanoma

    Discontinued [GID-IP1041]

    Interventional procedures guidance
    Discontinued

  10. GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain

    In development [GID-MT567] Expected publication date: TBC

    Medical technologies guidance
    In development

  11. DHT pilot: DECODE decision support system for the identification of dementia (Discontinued)

    Discontinued [GID-MT536]

    Medical technologies guidance
    Discontinued

  12. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)

    This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.

    NICE guideline
    Last updated
    13 August 2019
    View recommendations

    Sections for NG89

  13. The IN.PACT drug-coated balloon for peripheral arterial disease (CANCELLED)

    Discontinued [GID-MT517]

    Medical technologies guidance
    Discontinued

  14. ERC1671 for treating progressed or recurrent grade IV glioma (glioblastoma or gliosarcoma) [ID1623]

    In development [GID-TA10489] Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. SeQuent Please Neo balloon catheter for in-stent coronary restenosis - update of MTG1 (discontinued)

    Discontinued [GID-MT516]

    Medical technologies guidance
    Discontinued